National Health Act (Pharmaceutical Benefits – Early Supply) Amendment November 2009 specification under subsection 84AAA(2) (No. PB 103 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 103 of 2009

National Health (Pharmaceutical Benefits – Early Supply) Amendment November 2009 - Specification Under Subsection 84AAA(2)

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

I, Linda Jackson, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated          16     October 2009

Linda Jackson

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — Pharmaceutical Benefits-Early Supply

1          Name of Instrument

(1)      This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment November 2009 - specification under subsection 84AAA(2).

(2)      This Instrument may also be cited as “No. PB 103 of 2009”.

2          Commencement

This Instrument commences on 1 November 2009.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

Schedule 1        Amendments

1. Schedule 1, item dealing with Etanercept

omit from the column headed “Form (strength, type, size, etc.)”:

Injection 50 mg in 1 mL single use injection pen, 4

and substitute:

Injection 50 mg in 1 mL single use auto-injector, 4

1. Schedule 1, before item dealing with Ezetimibe with Simvastatin, Tablet 10 mg-40 mg

insert in the columns in the order indicated:

Tablet 10 mg-10 mg	Oral	30	5
Tablet 10 mg-20 mg	Oral	30	5

1. Schedule 1, item dealing with Lansoprazole

omit from the columns in the order indicated:

Capsule 30 mg	Oral	30	5
Sachet containing granules for oral suspension, 30 mg per sachet	Oral	28	5

1. Schedule 1, after item dealing with Valsartan with hydrochlorothiazide, Tablet 160 mg-25 mg

insert in the columns in the order indicated:

Tablet 320 mg-12.5 mg	Oral	28	5
Tablet 320 mg-25 mg	Oral	28	5